Clearstead Advisors, LLC Biogen Inc. Transaction History

Clearstead Advisors, LLC

$6.44 Billion
Q4 2024

A detailed history of Clearstead Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 1,118 shares of BIIB stock, worth $152,685. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,118

Previous 1,420 21.27%

Holding current value

$152,685

Previous $275,000 38.18%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$146.47 - $191.55 $44,233 - $57,848	-302 Reduced 21.27%	1,118 $170,000
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $6,995 - $8,761	-37 Reduced 2.54%	1,420 $275,000
Q2 2024 Aug 09, 2024	BUY	$190.52 - $236.72 $3,048 - $3,787	16 Added 1.11%	1,457 $337,000
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $82,051 - $103,603	-387 Reduced 21.17%	1,441 $310,000
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $25,375 - $30,545	114 Added 6.65%	1,828 $473,000
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $18,997 - $21,441	75 Added 4.58%	1,714 $440,000
Q3 2023 Nov 07, 2023	BUY	$253.3 - $285.89 $48,380 - $54,604	191 Added 13.19%	1,639 $421,000
Q2 2023 Aug 07, 2023	SELL	$275.25 - $318.06 $825 - $954	-3 Reduced 0.21%	1,448 $412,000
Q1 2023 May 09, 2023	SELL	$256.56 - $292.34 $513 - $584	-2 Reduced 0.14%	1,451 $403,000
Q1 2022 May 04, 2022	BUY	$193.77 - $244.14 $43,792 - $55,175	226 Added 18.42%	1,453 $306,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $47,694 - $61,295	213 Added 21.01%	1,227 $294,000
Q2 2021 Aug 12, 2021	BUY	$259.0 - $414.71 $127,428 - $204,037	492 Added 94.25%	1,014 $351,000
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $33,527 - $39,278	138 Added 35.94%	522 $146,000
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $30,183 - $34,850	114 Added 42.22%	384 $109,000
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $72,589 - $92,080	270 New	270 $85,000

Others Institutions Holding BIIB

# of Institutions

998

Shares Held

131M

Call Options Held

1.78M

Put Options Held

2.36M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $19.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Account

Clearstead Advisors, LLC Biogen Inc. Transaction History